7th Circuit Affirms Dismissal Of Prescription Drug Headline Fraud Case

7th Circuit Affirms Dismissal Of Prescription Drug Headline Fraud Case

CHICAGO - A panel of the Seventh Circuit U.S. Court of Appeals on July 8 affirmed the dismissal of a class action complaint alleging that a prescription drug manufacturer and pharmacy engaged in a scheme to defraud insurers (United Food and Commercial Unions and Employers Midwest Health Benefits Fund v. Walgreen Co., et al., No. 12-2077, 7th Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®